Organometallic Ligands

N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea is a systemic herbicide, which is synthesized from chloro- and methyl-substituted phenyl compounds. It exhibits its mode of action by inhibiting the photosystem II complex, thereby disrupting the electron transport chain during photosynthesis in susceptible plants. This leads to a decline in ATP and NADPH production, essential for plant growth and survival.

BMS-1166 is a small molecule immunotherapy agent that functions as a PD-1 antagonist. It is derived from targeted drug design, focusing on disrupting the interaction between the programmed cell death protein 1 (PD-1) and its ligands, PD-L1 and PD-L2.

LY 266097 Hydrochloride is a selective 5-HT2A receptor antagonist, which is a synthetic compound primarily used in neuroscience research. This compound is derived from laboratory synthesis, designed to interact specifically with serotonin receptors located in the central nervous system.

Please enquire for more information about KYT 0353 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Cardanol monoene is a phenolic lipid, which is a natural derivative obtained from cashew nut shell liquid. It is sourced from the renewable agricultural by-product of the Anacardium occidentale, allowing for a sustainable means of production. Its chemical structure features a phenolic ring with an aliphatic chain, which imparts unique properties that facilitate its mode of action.

Bio-013077-01 is a bioactive compound, which is a naturally derived product sourced from marine organisms. Its mode of action involves functioning as an enzyme inhibitor, capable of selectively binding to specific target enzymes and altering their activity. This mechanism allows it to modulate biochemical pathways that are crucial for various physiological and pathological processes.

Pglu-Pro-Arg-mna monoacetate is a synthetic peptide inhibitor, which is typically derived from biochemical synthesis processes involving solid-phase peptide synthesis. Its primary mode of action is the competitive inhibition of certain enzyme activities, commonly within the realm of proteolytic enzymes. By mimicking substrate structures, it effectively binds to the enzyme's active site, thereby preventing the actual substrate from interacting and consequently inhibiting the enzyme's activity.

BOP is a coupling reagent, which is derived from phosphonium sources and employed in peptide synthesis. It functions by facilitating the formation of peptide bonds between amino acids through its highly effective activation mechanism. BOP acts as an agent that promotes the formation of amide bonds, crucial in the construction of polypeptide chains.

SB-242084 hydrochloride is a selective antagonist of 5-HT2C receptors, which is a synthetic compound developed to study serotonergic pathways in neuroscience research. This compound originates from pharmaceutical research efforts to explore new avenues for modulating serotonin receptor subtypes, offering specificity for 5-HT2C receptors with minimal activity against 5-HT2A and 5-HT2B receptors.

BP 554 maleate is a synthetic compound, specifically a chemical analog, which is primarily derived through laboratory synthesis processes. It functions as a potential antihypertensive agent by acting on specific biochemical pathways to modulate vascular tone. The mode of action involves interfering with receptor sites or enzymatic pathways, which subsequently results in the relaxing of vascular smooth muscles and a decrease in peripheral vascular resistance. This compound has been studied for its utility in managing conditions related to elevated blood pressure and might offer insights into novel therapeutic approaches for cardiovascular disease management. As such, BP 554 maleate serves as a valuable tool in pharmacological research, particularly in the exploration of cardiovascular therapeutics and the development of new drug formulations aimed at optimizing blood pressure control.

Arginino-succinic acid disodium is a dicarboxylic acid salt, which is a derivative of argininosuccinic acid in its sodium salt form. This compound is synthesized through enzymatic reactions involving citrulline and aspartate, culminating in the production of argininosuccinate. The mode of action involves its participation as a substrate in the urea cycle, catalyzed by the enzyme argininosuccinate lyase, where it is cleaved into arginine and fumarate. Arginino-succinic acid disodium plays a pivotal role in the detoxification of ammonia in biological systems, facilitating its conversion into urea.

CGP 78608 is a neuropeptide Y (NPY) Y5 receptor antagonist, which is a synthetic compound derived from a complex series of chemical syntheses. The source of this product lies in tailored organic chemistry processes designed to precisely inhibit specific receptor subtypes associated with neuropeptide Y.

Zoledronic acid monohydrate EP Impurity B is a chemical impurity often encountered in the synthesis and quality control of zoledronic acid. This impurity arises from synthetic pathways involved in the production of bisphosphonates, a class of compounds used for bone-related conditions. As an impurity, it does not have direct therapeutic action but plays a significant role in the characterization and purity assessment of pharmaceutical formulations.

CTX-712 is an innovative small-molecule inhibitor, which is synthesized through state-of-the-art organic chemical processes. This compound functions by selectively targeting and inhibiting specific intracellular pathways critical for tumor cell proliferation and survival. Through its precise mechanism of disrupting key signaling cascades, CTX-712 effectively impairs the growth of cancer cells while minimizing the impact on normal, healthy tissues.

SIRT1 Activator II is a biochemical compound known as a small molecule activator. It is derived from synthetic sources, specifically engineered to interact with cellular pathways involved in aging and metabolism. The mode of action of SIRT1 Activator II involves the activation of the SIRT1 enzyme, a member of the sirtuin family of NAD+-dependent deacetylases. This activation results in the modulation of gene expression relevant to cellular stress resistance, metabolic regulation, and longevity.

p38 MAP kinase antagonist

Perfluorophenyl 19-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-17-oxo-4,7,10,13-tetraoxa-16-azanonadecan-1-oate is a synthetic compound, which is derived through a series of complex organic syntheses involving perfluorinated reagents. This compound is meticulously designed to incorporate both perfluorinated aromatic groups and a flexible, polyether-based linker. The mode of action for this compound primarily revolves around its unique chemical structure, which facilitates interactions at the molecular level that can be favorable for a variety of biochemical applications.

Potent P-glycoprotein (P-gp) inhibitor

AZD5069 is a small molecule that serves as a potent and selective antagonist of the CXC chemokine receptor 2 (CXCR2). It is derived from synthetic pharmaceutical research efforts aimed at targeting key signaling pathways in inflammatory diseases. This compound functions by inhibiting the CXCR2 receptor, which plays a critical role in the recruitment and activation of neutrophils, a type of white blood cell involved in inflammation and immune responses.

BIBF 1202 is a potent inhibitor of phospholipase A2, prostaglandin synthase and cyclooxygenase-2. It inhibits the production of arachidonic acid from membrane phospholipids and is used in cancer research. BIBF 1202 has been shown to have anti-tumour activity in a number of animal models, including human liver cancer cells. This molecule has also been shown to inhibit the activation of nuclear factor kappa B (NF-κB), which is involved in carcinogenesis.

Methyl-d3-magnesium iodide solution, 1.0 M in diethyl ether, is a specialized organometallic reagent used extensively in synthetic chemistry. This compound is a labeled Grignard reagent, where the methyl group is fully deuterated. It is sourced through the synthesis involving the reaction of deuterated methyl iodide with magnesium in an anhydrous diethyl ether solvent.

BMY 7378 Dihydrochloride is a selective 5-HT1A receptor antagonist, which is synthetically derived for specialized research purposes. This compound is known for its ability to bind exclusively to the 5-HT1A receptor, inhibiting the action of serotonin. Its mechanism of action involves a high-affinity blockade of serotonin at this receptor site, making it a valuable tool for understanding serotonergic signaling pathways.

SMN-C3 is a synthetic compound designed specifically as a targeted therapeutic agent. It is derived through advanced chemical synthesis techniques, utilizing a meticulous approach to optimize efficacy and specificity. The mode of action of SMN-C3 involves precise interaction with select molecular targets, thereby modulating biological pathways with high specificity. This interaction is designed to alter the course of disease processes, offering potential therapeutic benefits.

KUNB31 is a synthetic enzyme inhibitor, which is an engineered compound designed to interfere with the activity of specific enzymes in various biochemical pathways. This product is synthesized through a series of complex chemical reactions, ensuring high specificity and activity against target enzymes. Its mode of action involves binding to the active sites of enzymes, thereby preventing substrates from interacting and altering enzymatic activity.

HMG-CoA reductase antagonist

(S)-Luliconazole is an antifungal agent that is synthesized from an imidazole compound. This compound is biphenyl in structure and is often derived through chiral synthesis techniques to isolate the (S)-enantiomer, which is the active form that enhances pharmacological effects. Its mode of action involves inhibiting the enzyme lanosterol 14α-demethylase, an essential component in fungal cell membrane synthesis. This inhibition disrupts the production of ergosterol, a critical sterol in fungal membranes, ultimately leading to increased membrane permeability and cell death.

Budralazine is a synthetic vasodilator, which is derived from a series of hydrazine analogs, known for their ability to modulate vascular tone. Its mode of action involves the direct relaxation of vascular smooth muscle. This relaxation leads to a decrease in peripheral vascular resistance and, consequently, a reduction in blood pressure. Intriguingly, Budralazine is thought to selectively target arterioles over veins, making it of particular interest in the study of vascular dynamics and hypertension.

D1 and D2 dopamine agonist

A β2-adrenoceptor agonist that is structurally related to salbutamol. Ellicits β-adrenergic stimulatory effects on smooth muscles in trachea and bronchi. More effective (1.5 to 2 times more) as a bronchodilator than salbutamol.

Lanabecestat is an investigational drug, classified as a beta-secretase (BACE) inhibitor, which is derived from synthetic chemical processes. Its mode of action involves inhibiting the enzyme beta-secretase, which plays a crucial role in the amyloidogenic pathway by cleaving amyloid precursor protein (APP) into amyloid-beta peptides. The accumulation of these peptides is a hallmark of Alzheimer's disease pathology.

Hypoglycemic agent

H-9 hydrochloride is a selective protein kinase inhibitor, which is synthetically derived. It primarily inhibits cyclic nucleotide-dependent protein kinases, including protein kinase A (PKA) and protein kinase G (PKG), along with myosin light chain kinase (MLCK). The mode of action involves competitive inhibition at the ATP binding site of these kinases, thereby impacting phosphorylation pathways crucial for multiple physiological functions. The selective inhibition by H-9 hydrochloride allows for detailed exploration of kinase-mediated signaling pathways in cellular biology. Moreover, it is extensively utilized in studies involving cell motility, smooth muscle contraction, and signal transduction. The relevance of H-9 hydrochloride in academic research lies in its ability to provide insights into kinase activity modulation and its ensuing effects on cellular dynamics. This compound serves as an invaluable tool for scientists aiming to elucidate the complex role of protein kinases in health and disease, enabling the development of innovative therapeutic strategies.

nAChRs nicotinic receptor antagonist; neuromuscular-blocking agent

ALX-1393 is a synthetic compound that acts as an inhibitor, specifically targeting the glycine transporter 1 (GlyT1). As a small molecule inhibitor derived from chemical synthesis, it modulates neurotransmitter systems by blocking the reuptake of glycine, an important co-agonist of the NMDA receptor, in the central nervous system. The mode of action of ALX-1393 involves binding to the GlyT1 transporter, thereby increasing the synaptic concentration of glycine. This elevation in glycine levels enhances NMDA receptor function, which is crucial for synaptic plasticity, learning, and memory.

1,2-Dipalmitoyl-3-dimethylammonium-propane is a cationic lipid, which is a type of synthetic lipid commonly used in biochemical and biophysical research. It is sourced from chemical synthesis, involving the formulation of lipid molecules with specific chemical modifications to confer particular properties. The mode of action of this compound involves its ability to integrate into lipid bilayers and form liposomes. These liposomes can encapsulate nucleic acids, facilitating their delivery into cells by merging with cell membranes, which is crucial for gene delivery applications.

L-MobileTrex is an advanced analytical technology platform, which is a product of cutting-edge research in data science and computational modeling. This platform operates by integrating multi-dimensional datasets through sophisticated algorithms, providing enhanced data visualization and interpretability.

CB-1158 is an arginase inhibitor, which is a small molecule derived from a synthetic source designed to modulate immune functions. Its mode of action involves the inhibition of the arginase enzyme, a key player in the urea cycle responsible for the hydrolysis of arginine into ornithine and urea. By blocking arginase, CB-1158 effectively prevents the depletion of extracellular arginine, a vital amino acid required for the activation and proliferation of T cells within the immune system. This inhibition leads to enhanced immune responses against tumors.